📩 The #ESWI #Fluzine for #February is live!
💻 #IDC Kick-off | 5 Mar, Online — respiratory viruses & #NCDs
📅 ESWI Summit | 11 Jun, Brussels — vaccines & immunisation policy
🎥 #ESWI2025 Science Policy sessions now available
📍 Explore our #ESWIEducationHub
🔗 mailchi.mp/eswi/fluzine...
Award winning STEM holiday camps for curious kids.
The highlight of every school holiday break.
Book now www.junioreinsteinsscienceclub.com
#KidsCamps
#HolidayCamps
#SchoolHolidayCamps
#EasterCamps
#HalfTermCamps
#MidTermCamps
#WinterCamps
#PADayCamps
#KidsActivities
#junioreinsteins
🛎️ … Not just a respiratory virus!
Viral hepatitis remains a major global health challenge, with many individuals undiagnosed or lost to follow-up. Learn how to bridge gaps in screening and treatment in this live webinar, hosted by PRIME Education, on March 10, 2026.
📆 Register here: https://ow.ly/Rwnp50Y9il5
#ISID #CME #MedEd
💡An important commentary on vaccines from ESCMID by the Vaccines Subcommittee Director, the Chair of the Vaccines Study Group & the ESCMID Executive Committee jointly published in CMI & CMI Comms.
CMI: https://ow.ly/HUGM50XNByv
CMI Comms: https://ow.ly/xmbk50XNByx
#IDSky #clinmicro
You can also find more information about #RSV on the European Vaccination Information Portal - #EVIP in YOUR language!
Check it out here: vaccination-info.europa.eu/en/rsv
#UnitedInProtection #VaccinesSaveLives #VaccinesWork #ChildHealth #PublicHealth
📢 Call for Abstracts!
Submit your abstracts for SHEA Spring 2026 by January 13, 2026, at 11:59 p.m. ET.
Don’t miss your chance to share your research with leaders in healthcare epidemiology and infection prevention.
bit.ly/4qNoqNU
Night view of Belfast City Hall illuminated with colourful lights, promoting abstract submission closing for Annual Conference 2026 at ICC Belfast from April 13-16.
One week to go! Abstract submissions for Annual Conference 2026 close at 23:59 GMT on Tuesday 11 November. If you study microbes, there’s a home for your work at #Microbio26
Submit your work to one of >20 available sessions at: microb.io/AC26Abstracts
🚨 Only 2 weeks left to apply! Pasteur Course: The Last Mile – Towards Elimination of Major Infectious Diseases
Join a unique intensive course tackling the current challenges and critical advances in the fight against infectious diseases.
👉 Register now before November 22! bit.ly/4r1RpxE
Last chace to register for this year's Influenza Update Meeting - and places are going fast. Don't miss out!
Looking forward to seeing you there, flu people
Getting--or got--a PhD? Got boogie in your soul? Then don't be shy. Enter this year's contest--and dance, dance, dance! @science.org
How can public engagement transform how we teach #Immunology?
Join this parallel session organised by the BSI Teaching Affinity Group at BSI Congress to explore how collaboration and lived experience enrich education & research.
Register for #BSI25: https://bit.ly/3IkxWq8
#ESWI2025 I #ScienceCommunication #Trust #RiskCommunication #PublicHealth
Frédéric Bouder @unistavanger.bsky.social 🇳🇴
✅ Effective communication of benefits and risks is a key factor in building #Trust
🧭 The three pillars of #Trust: Fairness, Competence, Efficiency
📜 At #ESWI2025 Maria Zambon traces the history of how we understand pandemics — from religious interpretations to the rise of rational, evidence-based therapeutics
A fascinating look at how science reshaped our view of disease and response🧠
#PublicHealth #Pandemic #History
ESCAIDE 2025 is just around the corner! We are looking forward to seeing you in Warsaw or online on 19-21 November.
You can still register to join us virtually: lnkd.in/dHvsXxqr
Get a preview of our programme featuring key topics in public health and epidemiology: lnkd.in/d6ZM-ZYT
Vaccination against herpes zoster, or shingles, is linked to lower risks of heart disease, dementia and death in people age 50 and older, according to new research presented at #IDWeek2025. https://bit.ly/471biNp
✈️ Next stop: #ESWI2025 in Valencia!
We’re excited to join global experts in infectious disease control, antimicrobial stewardship, and vaccine innovation.
Looking forward to sharing insights, forging collaborations, and advancing prevention together.
#VIVI #InfectionPrevention
⏰#ERSCongress ALERT
📰 Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial
🔓 Online now and free to access for all: tinyurl.com/4nhbtj89
Long Covid Risk for Children Doubles After a Second Infection, Study Finds.
Children you say?
#longCOVID
www.nytimes.com/2025/09/30/h...
Spaces are filling fast! Register for our bioinformatics training starting Monday 20 October 👉 bit.ly/4emxfIt
Thank you for joining @promedmail.org’s 31st anniversary! Your support helps us strengthen systems, better serve our users, and continue sharing trusted outbreak alerts worldwide.
Here’s to many more years protecting global health ✨ #ISID
ow.ly/En2C50WGWqm
Microbial communities of grapevines vary between wine regions, grape variety, climate, geography and vineyard practices. 🍇
This #FEMSmicroBlog explains how the well-adapted yeast species Hanseniaspora shapes grape fermentation and thus the final wine product. #FascinatingMicrobes
🌍 At @ESCMID #VaccinesConference in Lisbon, #Pandemic #Preparedness is in focus (Day 3 & Day 5).
From surveillance to vaccines, global cooperation is key to staying ahead of future threats.
Prevention today means resilience tomorrow.
#UnitedInProtection
👉 bit.ly/ViVI-Prep2025
Did you know the next pandemic is likely to emerge from one of 25 or so viral families?
Learning as much as possible about them now & building a library of knowledge is helping scientists get ahead of this threat.
Discover the families in CEPI's The Viral Most Wanted ➡️ cepi.net/viral-most-w...
Credit: Adria Volta
📰The Lancet Respiratory Medicine’s September issue is out now
Read content on obstructive sleep apnoea, #tuberculosis, cardiogenic shock, #pneumonia, and much more
Check out the full issue here: bit.ly/3P2PVls
New Research:
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
www.thelancet.com/journals/lan...
"On the one hand, we have a hypothesis underpinned by evidence, although imperfect, and on the other hand we have a hypothesis without evidence, although it might exist."
Our latest editorial in advance of our August issue
www.thelancet.com/journals/lan...
#IDSky #ClinMicro #ViroSky #SARS-CoV-2
Response to Letter to the Editor, Re: The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study
✅ Just Accepted
#IDSky
For 31 years, @promedmail.org has led the way in reporting major and minor disease outbreaks, like being the first to alert the world to #COVID19. Our experts work around the clock to detect and share outbreak intelligence worldwide. #ISID
Make a gift today: ow.ly/X70M50WGWn4
